Table 4.
Long‐Term Outcomes
| Outcome | 12 months | 24 months |
|---|---|---|
| Cumulative MAEs | 12% (6/50) | 14.9% (7/47) |
| Clinically‐driven TLR | 12% (6/50) | 14.9% (7/47) |
| Index limb amputation | 0% (0/49) | 0.0% (0/44) |
| Cardiovascular death | 0% (0/49) | 0.0% (0/44) |
| Freedom from clinically driven TLR | 90.0% | 85.8% |
| Primary patency | 89.5% | 80.3% |
| Change in ABI compared with baselinea | 0.21±0.18b (36) | 0.22±0.13b (32) |
Data presented as % (n/N), survival percentage from KM analysis or Mean ± SD (N). ABI: ankle‐brachial index; TLR: target lesion revascularization.
a
Includes patients with baseline ABI < 0.9 only.
b
P‐value < 0.001 compared with baseline, paired t‐test.